SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (13627)8/18/1998 11:05:00 PM
From: VLAD  Read Replies (2) of 23519
 
martin,

Astra can not partner nor purchase Vivus because of legalities with Merck. Leaves only one obvious candidate for partnering or aquiring Vivus. Janssen isn't going to dump all this money into milestone payments to give their territories away. He who has Asia will make the most on this product. Janssen is a part of JNJ. They have approval in and are above us in Canada and below us in Mexico. If JNJ swollows Vivus they will have the entire North America. Excluding Astra's territory, once Asia is fully launched and with the US and Japan included, MUSE should bring in gross sales of over one billion dollars even with Viagra.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext